Clinical trial
Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon
NCT00297882 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00297882 |
|---|---|
| Title | Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon |
| Official title | Phase III Clinical Trials of Artemisinin-based Combination Therapy in Cameroon |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | University of Yaounde Cameroon Baptist Convention Health |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | 1. Artemether-Lumefantrine (AL), 2. Amodiaquine-Artesunate (AQ-AS) |
| Enrollment | 816 |
| Start date | Jul 1, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Mar 1, 2006 |
| Last update posted | Jun 8, 2021 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: